Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial.

BACKGROUND: Sarcopenia plays a central role in the development of frailty syndrome. Nutrition and exercise are cornerstone strategies to mitigate the transition to frailty; however, there is a paucity of evidence for which dietary and exercise strategies are effective. OBJECTIVE: This large, multifactorial trial investigated the efficacy of different dietary strategies to enhance the adaptations to resistance training in pre-frail and frail elderly. METHODS: This was a single-site 16-week, double-blind, randomized, placebo-controlled trial conducted at the Clinical Hospital, School of Medicine - University of São Paulo, Sao Paulo, Brazil. Four integrated, sub-investigations were conducted to compare: 1) leucine vs. placebo; 2) whey vs. soy vs. placebo; 3) creatine vs. whey vs. creatine plus whey vs. placebo; 4) women vs. men in response to whey. Sub-investigations 1 to 3 were conducted in women, only. Two-hundred participants (154 women/46 men, mean age 72 ± 6 years) underwent a twice-a-week, resistance training program. The main outcomes were muscle function (assessed by dynamic and isometric strength and functional tests) and lean mass (assessed by DXA). Muscle cross-sectional area, health-related quality of life, bone and fat mass, and biochemical markers were also assessed. RESULTS: We observed that leucine supplementation was ineffective to improve muscle mass and function. Supplementation with whey and soy failed to enhance resistance-training effects. Similarly, supplementation with neither whey nor creatine potentiated the adaptations to resistance training. Finally, no sex-based differences were found in response to whey supplementation. Resistance exercise per se increased muscle mass and function in all sub-investigations. There were no adverse effects. CONCLUSION: Neither protein (whey and soy), leucine, nor creatine supplementation enhanced resistance training-induced adaptations in pre-frail and frail elderly, regardless of sex. These findings do not support the notion that some widely used supplement-based interventions can add to the already potent effects of resistance exercise to counteract frailty-related muscle wasting and dynapenia. CLINICAL TRIAL REGISTRY: NCT01890382; https://clinicaltrials.gov/ct2/show/NCT01890382. DATA SHARING: Data described in the manuscript will be made available upon request pending application.

Maternal soy protein isolate diet during lactation programmes to higher metabolic risk in adult male offspring.

Soy consumption and its components, including its protein, are related to the beneficial effects of the lipid profile, decreased insulin resistance and glycaemia. However, the safety of the consumption of products containing phytoestrogens in critical stages of development has been questioned, since they may be associated with endocrine-metabolic dysfunctions in adult life. The purpose is to evaluate the effects of maternal dietary soy protein isolate (SPI) during lactation on the breast milk composition, body composition, lipid and glycaemic profiles, and thyroid hormones of dams and offspring at weaning (21 days) and in adulthood (150 days). Lactating rats were divided into casein control (C) and SPI diet groups. At 150 days, the SPI offspring presented lower body protein mass and total mineral content, higher serum FT4, insulin, TC and TG. Maternal consumption of SPI during lactation programmes the progeny to higher metabolic risk profile.

Soybean -conglycinin Induces Intestinal Immune Responses in Chicks

Conglycinin from soybean has been recognized as one of the major feed allergens. This study investigated the effects of -conglycinin-induced allergic sensitization on chicks small intestines. A total of 40 7-day-old (100 g) chicks were divided into four groups as control, -conglycinin 1 h, -conglycinin 6 h, and -conglycinin 12 h. All treatment groups were administered 60 mg of -conglycinin/chick and small intestine samples were collected. -conglycinin-induced allergic sensitization marginally damages the epithelium lining of the duodenum villi and, in addition, significantly increases the accumulation of mast cells in the lamina propria and crypt of the duodenum. Moreover, the TNF- level significantly increased in all -conglycinin groups. IL-8 and IL-2 were significantly downregulated in the 1 h group; however, there were increases for the 6 h and 12 h groups. These results suggest that -conglycinin may lead to an inflammatory response in the chicks small intestines.

Soybean -conglycinin Induces Intestinal Immune Responses in Chicks

Conglycinin from soybean has been recognized as one of the major feed allergens. This study investigated the effects of -conglycinin-induced allergic sensitization on chicks small intestines. A total of 40 7-day-old (100 g) chicks were divided into four groups as control, -conglycinin 1 h, -conglycinin 6 h, and -conglycinin 12 h. All treatment groups were administered 60 mg of -conglycinin/chick and small intestine samples were collected. -conglycinin-induced allergic sensitization marginally damages the epithelium lining of the duodenum villi and, in addition, significantly increases the accumulation of mast cells in the lamina propria and crypt of the duodenum. Moreover, the TNF- level significantly increased in all -conglycinin groups. IL-8 and IL-2 were significantly downregulated in the 1 h group; however, there were increases for the 6 h and 12 h groups. These results suggest that -conglycinin may lead to an inflammatory response in the chicks small intestines.(AU)

Fórmulas nutricionais para crianças com alergia à proteína do leite de vaca / Nutrition formulas for children with allergy to cow's milk protein

CONTEXTO: A APLV é o tipo de alergia alimentar mais comum nas crianças até vinte e quatro meses e é caracterizada pela reação do sistema imunológico às proteínas do leite. Dados internacionais mostram prevalência de crianças com APLV que variam de 0,3% a 7,5% até os dois anos de idade. Não há pesquisas ou inquéritos nacionais sobre a prevalência da APLV no Brasil. No entanto, em agosto de 2012, o MS realizou um levantamento nos municípios brasileiros, nos quais foi identificada média de acompanhamento de 0,4% (0,2% a 0,7%) de crianças com APLV em serviços/programas de atenção nutricional estruturados nesses municípios pelo SUS. A conduta na APLV baseia-se na exclusão da proteína alergênica da dieta; prescrição de dieta substitutiva que proporcione todos os nutrientes necessários em crianças até 6 meses; prescrição de alimentação complementar (de 6 a 24 meses). As fórmulas infantis para necessidades dietoterápicas específicas são indicadas para crianças de até vinte e quatro meses de idade. TECNOLOGIA: As fórmulas nutricionais utilizadas na APLV são as fórmulas à base de soja (FS), à base de proteína extensamente hidrolisada (FEH) com ou sem lactose e à base de aminoácidos (FAA). As FEH são indicadas como primeira opção para todas as crianças até vinte e quatro meses com APLV não mediada por IgE e são toleradas em 90% dos casos de crianças menores de seis meses e em 95% das crianças acima de seis meses. Para crianças de seis a vinte e quatro meses com formas de APLV mediadas por IgE, a primeira opção deve ser a prescrição de FS. Somente 10% das crianças menores de seis meses e 5% das crianças acima de seis meses não toleram FEH, sendo necessário o uso de FAA. AVALIAÇÃO DE IMPACTO ORÇAMENTÁRIO: Com os preços de compra das fórmulas nutricionais praticados pelas Secretarias Estaduais de Saúde que responderam ao levantamento feito pelo CONASS, o impacto orçamentário seria de R$ 79.631.103,17 no primeiro ano de incorporação e de R$ 659.212.776,41 em cinco anos de incorporação. RECOMENDAÇÃO PRELIMINAR DA CONITEC: os membros da CONITEC recomendaram que o tema fosse submetido à consulta pública com recomendação preliminar favorável à incorporação no SUS das fórmulas nutricionais para tratamento de crianças de 0 a 24 meses de idade com alergia à proteína do leite de vaca. CONSULTA PÚBLICA: Foram recebidas 69 contribuições técnico-científicas e 252 contribuições de experiência ou opinião. A maioria das contribuições se referiu a aspectos relacionados ao Protocolo Clínico e Diretrizes Terapêuticas de APLV e estas não foram consideradas na avaliação da incorporação das fórmulas nutricionais. As contribuições que questionaram aspectos da incorporação das fórmulas relataram a inadequação da utilização da fórmula à base de proteína de soja, mas não apresentaram embasamento científico robusto, ou sugeriram a inclusão da fórmula à base de arroz, para a qual ainda existem questionamentos sobre eficácia e segurança. DELIBERAÇÃO FINAL: Os membros da CONITEC deliberaram por recomendar a incorporação das fórmulas nutricionais à base de soja, à base de proteína extensamente hidrolisada com ou sem lactose e à base de aminoácidos para crianças de 0 a 24 meses com alergia à proteína do leite de vaca (APLV). DECISÃO: Incorporar as fórmulas nutricionais à base de soja, à base de proteína extensamente hidrolisada com ou sem lactose e à base de aminoácidos para crianças de 0 a 24 meses com alergia à proteína do leite de vaca (APLV), no âmbito do Sistema Único de Saúde - SUS. Dada pela Portaria nº 67, publicada no DOU nº 226, seção 1, página 57, em 26 de novembro de 2018.

Soy protein supplement intake for 12 months has no effect on sexual maturation and may improve nutritional status in pre-pubertal children.

AIM: To evaluate the intake of a soy protein-based supplement (SPS) and its effects on the sexual maturation and nutritional status of prepubertal children who consumed it for a year. METHODS: Healthy children (n = 51) were recruited and randomly assigned to consume the lunch fruit juice with (n = 29) or without (n = 22) addition of 45 g of a commercial soy protein-based supplement (SPS) over 12 months. Nutritional assessment including anthropometry (bodyweight, height, triceps skinfold thickness, mid-upper arm circumference), body mass index (BMI), upper arm muscle area, arm muscle circumference, upper arm area, upper arm fat area data were derived from measures using usual procedures; age and gender-specific percentiles were used as reference. Sexual maturation was measured by Tanner stage. Isoflavones were quantified using liquid chromatography and tandem mass spectrometry. RESULTS: Height, BMI/age, weight/age and height/age were significantly different (P < 0.05) at 12 months between girls in the control and intervention groups. Statistically significant differences between groups by gender (P < 0.05) were found in boys in the control group for the triceps skinfold thickness and fat area. Nutritional status was adequate according to the World Health Organization parameters. On average, 0.130 mg/kg body weight/day of isoflavones were consumed by children, which did not show significant differences in their sexual maturation. CONCLUSION: Consumption of SPS for 12 months did not affect sexual maturation or the onset of puberty in prepubertal boys and girls; however, it may have induced an increase in height, BMI/age, height/age and weight/age of the girls, associated with variations in fat-free mass.

Processing traits and digestibility of extruded dog foods with soy protein concentrate.

Soya bean protein concentrate (SPC) with two particle sizes were evaluated on extrusion parameters, kibble formation, digestibility and palatability of dog foods. Eight diets were extruded: PBM-control diet based on poultry by-product meal (PBM); GM-a diet in which corn gluten meal (GM) replaced 45% of the diet protein; cSPC15%, cSPC30% and cSPC45%-diets in which SPC of coarse particle size (600 µm) replaced 15%, 30% and 45% of the diet protein; and sSPC15%, sSPC30% and sSPC45%-diets in which SPC of small particle size (200 µm) replaced 15%, 30% and 45% of the diet protein. The digestibility of nutrients was evaluated for the PBM, GM, cSPC45% and sSPC45% diets, using six dogs per food. The PBM, GM and cSPC45% diets were compared for palatability. Data were submitted for analysis of variance, and the means were compared by polynomial contrasts or Tukey's test (p < .05). The cSPC increased the specific mechanical energy (SME) application, extrusion temperature and pressure linearly, resulting in lower kibble density and higher expansion and starch gelatinization (SG) (p < .01). When comparing the PBM, GM, cSPC45% and sSPC45% diets, higher SME, extrusion temperature and pressure, SG and kibble expansion were verified for the cSPC45% diet (p < .05). The DM, fat and crude protein digestibility were similar among diets. Faecal pH, ammonia and lactate did not differ, demonstrating that the removal of oligosaccharides and soluble non-starch polysaccharides of SPC produces an ingredient with mostly non-fermentable fibre. Dogs preferred the PBM to the GM diet (p < .05), but consumed the PBM and cSPC45% foods equally. In conclusion, SPC exhibited good extrusion functionality, favouring kibble expansion and SG, with high digestibility, similar to that of PBM. The removal of soluble compounds from soya beans resulted in an ingredient with low fermentable fibre content, which did not alter faecal formation or characteristics.

Replacement of protein source in practical diets for Amazon River Prawn / Substituição de fonte proteica em dietas práticas para Camarão-da-Amazônia

The aim of this study was to evaluate the best level of substitution of fish meal (FM) by soybean meal (SBM), as protein source in practical diets for juveniles of Macrobrachium amazonicum. Juveniles, with initial mean weight of 0.16 ± 0.66 g, were stocked at a density equivalent to 150 juveniles m-2 in a recirculating aquaculture system. Treatments consisted of the proportions of fish meal and soybean meal (FM:SBM) in diets, namely: 0: 100, 20:80, 40:60, 70:30, 100:0 with five replicates per treatment. At the end of the 45 days trial, prawns were counted, measured, weighed, and the bromatological analysis of the whole body was performed. Survival remained above 94% in all treatments (p>0.05). A corporal bromatological analysis showed significant among treatments only for crude protein (p 0.05), making possible the use of soybean meal in diets for juveniles of Amazonian river prawn.

O objetivo deste trabalho foi avaliar o melhor nível de substituição da farinha de peixe (FP) pelo farelo de soja (FS), como fonte de proteína em dietas práticas para juvenis de Macrobrachium amazonicum. Juvenis com peso médio inicial de 0,16 ± 0,66 g foram estocados em uma densidade equivalente a 150 juvenis m-2 em sistema de recirculação. Os tratamentos consistiram das seguintes proporções de farinha de peixe e farelo de soja (FP:FS): 0:100, 20:80, 40:60, 70:30, 100:0 com cinco repetições por tratamento. Ao final de 45 dias de experimento, os camarões foram contados, medidos e pesados, bem como foi realizada análise bromatológica corporal. A sobrevivência manteve-se superior a 94% em todos os tratamentos (p>0,05). A análise bromatológica corporal apresentou diferenças significativas entre os tratamentos apenas para proteína bruta (p<0,05). Os resultados da análise de desempenho zootécnico demonstraram que a inclusão de até 30% de FS em substituição a FP (70:30) não interferiu significativamente no desempenho dos camarões, possibilitando uso do farelo de soja em dietas para juvenis de camarão amazônico.

Replacement of protein source in practical diets for Amazon River Prawn / Substituição de fonte proteica em dietas práticas para Camarão-da-Amazônia

The aim of this study was to evaluate the best level of substitution of fish meal (FM) by soybean meal (SBM), as protein source in practical diets for juveniles of Macrobrachium amazonicum. Juveniles, with initial mean weight of 0.16 ± 0.66 g, were stocked at a density equivalent to 150 juveniles m-2 in a recirculating aquaculture system. Treatments consisted of the proportions of fish meal and soybean meal (FM:SBM) in diets, namely: 0: 100, 20:80, 40:60, 70:30, 100:0 with five replicates per treatment. At the end of the 45 days trial, prawns were counted, measured, weighed, and the bromatological analysis of the whole body was performed. Survival remained above 94% in all treatments (p>0.05). A corporal bromatological analysis showed significant among treatments only for crude protein (p <0.05). The results of the production performance showed that the inclusion of up to 30% of SBM in replacement for FM (70:30) did not interfere, significantly, in the performance of the prawns (p>0.05), making possible the use of soybean meal in diets for juveniles of Amazonian river prawn.(AU)

O objetivo deste trabalho foi avaliar o melhor nível de substituição da farinha de peixe (FP) pelo farelo de soja (FS), como fonte de proteína em dietas práticas para juvenis de Macrobrachium amazonicum. Juvenis com peso médio inicial de 0,16 ± 0,66 g foram estocados em uma densidade equivalente a 150 juvenis m-2 em sistema de recirculação. Os tratamentos consistiram das seguintes proporções de farinha de peixe e farelo de soja (FP:FS): 0:100, 20:80, 40:60, 70:30, 100:0 com cinco repetições por tratamento. Ao final de 45 dias de experimento, os camarões foram contados, medidos e pesados, bem como foi realizada análise bromatológica corporal. A sobrevivência manteve-se superior a 94% em todos os tratamentos (p>0,05). A análise bromatológica corporal apresentou diferenças significativas entre os tratamentos apenas para proteína bruta (p<0,05). Os resultados da análise de desempenho zootécnico demonstraram que a inclusão de até 30% de FS em substituição a FP (70:30) não interferiu significativamente no desempenho dos camarões, possibilitando uso do farelo de soja em dietas para juvenis de camarão amazônico.(AU)

The impact of laboratory chow for rats in the experiments: Chemical and biological evaluation of nine grain-based diet options.

Cereal-based diets formulated as semi-purified diets can provide flexibility for researchers, enabling open controlled formulas, besides being cheaper than purified diets. Seeking to widen the researchers' options in their experimental design developments, we aimed at assaying the chemical score, growth performance and protein utilization of nine semi-purified experimental chows. These diets were formulated at 17.8%, 12% and 8% protein contents, using three variations of ingredients for each one, as follows: casein (C), casein+soybean meal (C+S, 1:1 w/w protein) and casein+soybean meal+corn gluten meal (C+S+G, 1:1:1 w/w protein), without cysteine supplementation and setting casein 17.8% (AIN-93G) as reference diet. The diets C and C+S (17.8%) had the Cys as the limiting amino acid once the addition of gluten turns the Lys as second limiting. All diets had the potential for promoting growth with body mass gain, feed conversion ratio (FCR; chow consumed per body weight gain, average 3.12) and feed efficiency ratio (FER; body weight gain per chow consumed, average 0.3), except for C+S+G 8% (FCR = 6 g; FER = 0.13). These variations were mainly due to the protein amounts independently from the protein ingredient used and could characterize the C+S+G 8% as unable to support growth. For the other parameters (digestibility, net protein ratio, net protein utilization and protein efficiency ratio), there were no relevant differences between the diets. We can conclude that 17.8%, 12% and 8% chows (C and C+S) allowed a proper combination of ingredients from the point of view of palatability, nutrient availability/utilization, metabolic processes, growth performance and feed utilization parameters.

Dietary soya protein improves intra-myocardial lipid deposition and altered glucose metabolism in a hypertensive, dyslipidaemic, insulin-resistant rat model.

This study investigates the effects of replacing dietary casein by soya protein on the underlying mechanisms involved in the impaired metabolic fate of glucose and lipid metabolisms in the heart of dyslipidaemic rats chronically fed (8 months) a sucrose-rich (62·5 %) diet (SRD). To test this hypothesis, Wistar rats were fed an SRD for 4 months. From months 4 to 8, half the animals continued with the SRD and the other half were fed an SRD in which casein was substituted by soya. The control group received a diet with maize starch as the carbohydrate source. Compared with the SRD-fed group, the following results were obtained. First, soya protein significantly (P<0·001) reduced the plasma NEFA levels and normalised dyslipidaemia and glucose homoeostasis, improving insulin resistance. The protein levels of fatty acid translocase at basal state and under insulin stimulation and the protein levels and activity of muscle-type carnitine palmitoyltransferase 1 were normalised. Second, a significant (P<0·001) reduction of TAG, long-chain acyl CoA and diacylglycerol levels was observed in the heart muscle. Third, soya protein significantly increased (P<0·01) GLUT4 protein level under insulin stimulation and normalised glucose phosphorylation and oxidation. A reduction of phosphorylated AMP protein kinase protein level was recorded without changes in uncoupling protein 2 and PPARα. Fourth, hydroxyproline concentration decreased in the left ventricle and hypertension was normalised. The new information provided shows the beneficial effects of soya protein upon the altered pathways of glucose and lipid metabolism in the heart muscle of this rat model.

Adding Soy Protein to Milk Enhances the Effect of Resistance Training on Muscle Strength in Postmenopausal Women.

Resistance training (RT) and high-quality protein ingestion improves muscle mass (MM) and strength (MS). However, no study has evaluated the effect of ingesting milk plus soy protein (SOY) on MM and MS in postmenopausal women (PW). Thus, the aim of this study was to evaluate the effects of adding SOY to milk on MM and MS after 16 weeks of RT. Thirty-two PW were randomized and allocated into two groups: placebo and RT (PL+RT, n = 16) and SOY and RT (SOY+RT, n = 16). The SOY+RT received 25 g of SOY while the PL+RT received 25 g of maltodextrin (placebo). All supplements were given in the form of a chocolate-flavored powder added to 200 mL of milk. The RT protocol consisted of eight total body exercises at 70% of one repetition maximum (1RM), three sets of 8-12 repetitions, 2-3 times/week. No differences were found in the baseline measures between groups (age, menopause status, anthropometric and nutrition patterns), except for protein intake, which was higher in the SOY+RT. Both groups increased the MM (bioimpedance) showing no difference between groups (PL+RT = 1.5 kg; SOY+RT = 1.1 kg). For MS, the SOY+RT showed a larger (p < .05) increase in 1RM of bench press (PL+RT = 6.7 kg; SOY+RT = 12.5 kg), knee extension (PL+RT = 3.7 kg; SOY+RT = 6.7 kg), total load (PL+RT = 15.1 kg; SOY+RT = 24.2 kg), and the total load exercises/MM (PL+RT = 0.3 kg; SOY+RT = 0.9 kg). These results suggest that adding SOY to milk combined with 16 weeks of RT resulted in more significant increases in MS in PW.

Evidence for Involvement of IL-9 and IL-22 in Cows' Milk Allergy in Infants.

Although allergic inflammation is characterized by a T helper (Th) 2-dominant immune response, the discovery of a role for new T cell subsets in inflammatory diseases has added an additional layer of complexity to the understanding of the pathogeneses of allergic diseases. We evaluated plasma cytokine profiles in infants with cows' milk allergy (CMA), who were being treated with an elimination diet. In a prospective, randomized and controlled study, infants (aged 8.4 ± 3.9 months) with CMA were treated with an elimination diet for 120 days, which replaced cows' milk with a hydrolysed soy protein formula (n = 26) or a free amino acid formula (n = 20). Blood samples were collected before treatment during active disease (T0) and after 120 days, when symptoms were absent (T1). Plasma cytokine concentrations were measured. Infants with CMA had higher plasma concentrations of interleukin (IL)-4 and IL-13 and lower concentrations of IL-9, IL-17A and interferon-γ, compared with healthy breast-fed infants. At T0, there was a positive correlation between blood eosinophil numbers and plasma concentrations of IL-4, IL-9, IL-17A and IL-22. Treatment with a cows' milk elimination diet resulted in a decrease in plasma IL-4, IL-9, IL-13 and IL-22 and an increase in plasma IL-17A. We conclude that IL-4 and IL-13 are elevated in active CMA. The association of IL-9 and IL-22 with eosinophilia, and the decrease in these two cytokines with cows' milk elimination, suggests that they both play a role in the symptoms observed in CMA and may be important targets for future interventions.

Soybean agglutinin-conjugated silver nanoparticles nanocarriers in the treatment of breast cancer cells.

Silver nanoparticles (AgNPs) induce diverse cell-death mechanisms, similar to those promoted by anticancer chemotherapeutics; however, they have not been tested in vivo because their action is not limited to cancer cells. Therefore, in vivo evaluations of their effectiveness should be developed with targeting systems. Breast cancer shows changes in the sugar expression patterns on cell surfaces, related to cancer progression and metastases; those changes have been identified previously by the specific binding of soybean agglutinin (SBA). Here is proposed the use of SBA to target the AgNP activity in breast cancer. For that, the present work reports the synthesis of AgNPs (3.89 ± 0.90 nm) through the polyol method, the generation of AgNP nanocarriers, and the bioconjugation protocol of the nanocarrier with SBA. The free AgNPs, the AgNP nanocarriers, and the SBA-bioconjugated AgNP nanocarriers were tested for cytotoxicity in breast cancerous (MDA-MB-231and MCF7) and non cancerous (MCF 10A) cells, using the MTT assay. AgNPs demonstrated cytotoxic activity in vitro, the non cancerous cells (MCF 10A) being more sensible than the cancerous cells (MDA-MB-231 and MCF7) showing LD(50) values of 128, 205, and 319 µM Ag, respectively; the nanoencapsulation decreased the cytotoxic effect of AgNPs in non cancerous cells, maintaining or increasing the effect on the cancer-derived cells, whereas the SBA-bioconjugation allowed AgNP cytotoxic activity with a similar behavior to the nanocarriers. Future experiments need to be developed to evaluate the targeting effect of the SBA-bioconjugated AgNP nanocarriers to study their functionality in vivo.

Effect of resistance training on resting metabolic rate and its estimation by a dual-energy X-ray absorptiometry metabolic map.

BACKGROUND/OBJECTIVES: Fat-free mass (FFM) is the major predictor of resting metabolic rate (RMR). As protein supplementation during resistance training may augment gains in FFM, we investigated the effects of resistance training combined with protein supplementation on RMR and whether RMR responses could be estimated by a dual-energy X-ray absorptiometry (DXA) metabolic map. SUBJECTS/METHODS: Healthy adults completed a whole-body periodized resistance training program consisting of 96 workouts (~9 months). Participants were randomly assigned to supplement with whey protein (whey; n=18), soy protein (soy; n=21) or carbohydrate (carb; n=22). RMR was measured using indirect calorimetry (RMR(IC)) and estimated by DXA metabolic mapping (RMR(MM)) pretraining and posttraining. RESULTS: RMR(IC) increased from pretraining to posttraining in the whole cohort (1653±302 to 1726±291 kcal/day, P=0.001) without differences between the groups. Delta RMR(IC) and RMR(MM) (73±158 vs 52±41 kcal/day were not significantly different by t-test (P=0.303), although they were not significantly correlated (r=0.081; P=0.535). Stepwise regression identified 43% of the shared variance in delta RMR(IC) using total serum thyroxine, RMR(IC) and FFM at baseline (P=0.009). CONCLUSIONS: These results indicate that 9 months of resistance training significantly increased RMR ~5% on average, but there was wide variability between individuals, which can be partially accounted for by changes in FFM and thyroid hormones.

Mechanisms underlying the beneficial effect of soy protein in improving the metabolic abnormalities in the liver and skeletal muscle of dyslipemic insulin resistant rats.

PURPOSE: The present study analyzes the effect of the replacement of dietary casein by soy protein on the mechanisms underlying dyslipidemia, liver steatosis and altered glucose and lipid metabolism in the skeletal muscle which developed in rats fed long-term a sucrose-rich diet (SRD). METHODS: Wistar rats were fed a SRD for 4 months. From months 4 to 8, half the animals continued with the SRD, and the other half were fed a SRD in which the source of protein casein was replaced by soy. The control group received a diet with cornstarch as source of carbohydrate. RESULTS: Compared to SRD-fed animals, the rats fed soy showed: A--in the liver: reduction of triglyceride and cholesterol storage and decreased steatosis; normalization of mature forms of the protein mass levels of SREBP-1 and the activities of lipogenic enzymes, while the protein mass level of PPAR-α and fatty acid oxidase activity increased. B-in the gastrocnemius muscle: normalization of the enhanced lipid storage and the altered glucose oxidation, improving glucose phosphorylation; decreasing protein mass level of nPKCθ in the membrane fraction; reversion of the impaired insulin-stimulated glucose transporter Glut-4, and glucose-6-phosphate and glycogen concentrations. Besides, dyslipidemia and glucose homeostasis returned to control values. CONCLUSIONS: This study provides new information concerning some key mechanisms related to the effect of dietary soy on hepatic lipid metabolism and insulin action in the skeletal muscle in the presence of pre-existing dyslipidemia and insulin resistance induced by a SRD.

Elaboração e avaliação sensorial de doce de manga cremoso acrescido de farinha de Okara / Preparation and sensory evaluation of cream mango plus of Okara flour

The okara is a byproduct of soy aqueous extract that contains proteins of good nutritional quality. This study aimed to develop and characterize sensory sweet mango cream plus okara flour. Three formulations were prepared: control (no addition of flour) and containing 1% and 3% flour okara. The sensory evaluation was conducted with 100 untrained judges, using hedonic scales of nine points for the attributes color, aroma, texture, flavor and overall impression, beyond purchase intent using the structured scale of five points. For the color control samples and containing 1% and 3% okara flour not show any difference. For aroma, texture, flavor, overall impression and purchase intent was observed that the control samples and increased by 1% did not differ, and had means higher than the sample containing 3% of okara. The addition of okara flour to sweet mango cream showed good acceptance, so this product is a new alternative for processing industry the fruit having low production cost. (AU)

o okara é um subproduto do processamento do extrato aquoso de soja e contém proteínas de boa qualidade nutricional. Este trabalho objetivou elaborar e caracterizar sensorialmente doce de manga cremoso acrescido de farinha de okara. Foram elaboradas três formulações: controle (sem adição de farinha) e contendo 1% e 3% de farinha de okara. A avaliação sensorial foi realizada com 100 julgadores não treinados, utilizando escala hedônica de nove pontos para os atributos cor, aroma, textura, sabor e impressão global, além da intenção de compra usando a escala estruturada de cinco pontos. Para o atributo cor as amostras controle e contendo 1% e 3% de farinha de okara não apresentaram diferença entre si. Observou-se que as características aroma, textura, sabor, impressão global e a intenção de compra das amostras controle e adicionada de 1% de farinha não diferiram entre si, e apresentaram médias superiores à amostra contendo 3%. O doce de manga cremoso contendo farinha de okara apresentou boa aceitabilidade sensorial e possui baixo custo de produção, o que toma o produto uma nova alternativa para a indústria processadora de frutas. (AU)

Effect of fishmeal replacement by soy protein concentrate with taurine supplementation on hepatic intermediary metabolism and antioxidant status of totoaba juveniles (Totoaba macdonaldi).

The effect of dietary incorporation of soy protein concentrate (SPC) and the concomitant supplementation with taurine on hepatic intermediary metabolism and antioxidant status of totoaba (Totoaba macdonaldi) juveniles was assessed. Four isoproteic and isolipidic diets were formulated containing either 30 or 60% of SPC (diets SP30 and SP60), supplemented or not with 1% of taurine (diets SP30T and SP60T). A fish meal (FM) based diet, without SPC and taurine supplementation, was used as a control. Triplicate groups of 32 totoaba juveniles (average body mass=7.5g) were fed these diets over 45days. Results revealed that dietary FM replacement by SPC depressed the overall intermediary metabolism. Activity of key enzymes of amino acid catabolism and gluconeogenesis was significantly reduced and a trend to reduce glycolysis and glucose-6-phosphate dehydrogenase activity was observed. The incorporation of the highest level of SPC also significantly increased hepatic lipid peroxidation and the activity of superoxide dismutase. Concomitant taurine supplementation restored the activity of amino acid catabolic and gluconeogenic enzymes and hexokinase to levels similar of those of the control diet. Taurine supplementation also led to a significant increase of glucose-6-phosphate dehydrogenase and catalase activity, as well as to a significant reduction of liver lipid peroxidation. These results suggest that taurine may play an important metabolic modulation action on totoaba fed SPC based diets, contributing to the enhancement of the overall metabolism and to the reduction of liver oxidative damage.

The addition of whole soy flour to cafeteria diet reduces metabolic risk markers in wistar rats.

BACKGROUND: Soybean is termed a functional food because it contains bioactive compounds. However, its effects are not well known under unbalanced diet conditions. This work is aimed at evaluating the effect of adding whole soy flour to a cafeteria diet on intestinal histomorphometry, metabolic risk and toxicity markers in rats. METHODS: In this study, 30 male adult Wistar rats were used, distributed among three groups (n = 10): AIN-93 M diet, cafeteria diet (CAF) and cafeteria diet with soy flour (CAFS), for 56 days. The following parameters were measured: food intake; weight gain; serum concentrations of triglycerides, total cholesterol, HDL-c, glycated hemoglobin (HbA1c), aspartate (AST) and alanine (ALT) aminotransferases and Thiobarbituric Acid Reactive Substances (TBARS); humidity and lipid fecal content; weight and fat of the liver. The villous height, the crypt depth and the thickness of the duodenal and ileal circular and longitudinal muscle layers of the animals were also measured. RESULTS: There was a significant reduction in the food intake in the CAF group. The CAFS showed lower serum concentrations of triglycerides and serum TBARS and a lower percentage of hepatic fat, with a corresponding increase in thickness of the intestinal muscle layers. In the CAF group, an increase in the HbA1c, ALT, lipid excretion, liver TBARS and crypt depth, was observed associated with lower HDL-c and villous height. The addition of soy did not promote any change in these parameters. CONCLUSIONS: The inclusion of whole soy flour in a high-fat diet may be helpful in reducing some markers of metabolic risk; however, more studies are required to clarify its effects on unbalanced diets.